H.R. 2450 (119th)Passage Likelihood
Prescription Drug Transparency and Affordability Act
Health|Health
Sponsor
Cosponsors
Support
Bipartisan
Introduced
Mar 27, 2025
Discussions
Current stageCommittee
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced
Committee
Floor
President
Law
Loading passage likelihood analysis...